Brazilian Critical Minerals Issues 8.4 Million Shares Following BCMAF Option Exercises at $0.011 Each

BCMAF Options Exercised at $0.011 Result in New Ordinary Shares

On 1 July 2026, Brazilian Critical Minerals Limited submitted an Appendix 2A to ASX requesting quotation of 8,395,832 newly issued fully paid ordinary shares. These shares were created through the exercise of BCMAF options, which carry an exercise price of $0.011 per option and expire on 12 August 2027. The last exercise date recorded for these options was 1 July 2026.

With an exercise price of $0.011 per share, the company received cash consideration in Australian dollars for all 8,395,832 options exercised. Based on the exercise price and the number of shares issued, the gross proceeds from this conversion are approximately $92,354, although the company did not disclose the net proceeds in this update. The new shares are intended to be quoted on the ASX and rank equally in all respects with existing BCM ordinary shares from their issue date of 1 July 2026.

Total BCM Ordinary Shares Reach Nearly 1.97 Billion

Following this latest tranche of securities, Brazilian Critical Minerals’ total quoted ordinary shares now stand at 1,969,019,998. This figure is generated automatically by ASX systems during the Appendix 2A filing process. The company noted that these numbers may not fully reflect its current issued capital if other related filings are being processed concurrently.

For investors tracking the company’s capital structure, reaching nearly 1.97 billion quoted shares marks an important milestone. Such share counts are common among early-stage ASX-listed explorers, where ongoing capital raisings, option issuances, and conversions are typical methods to fund exploration. The gradual exercise of outstanding options allows holders to realise their positions while providing the company with incremental working capital.

Remaining 104.6 Million BCMAF Options Indicate Potential Future Dilution

Despite this recent conversion, 104,595,830 BCMAF options remain outstanding and unquoted. These options share the same $0.011 exercise price and 12 August 2027 expiry date. If exercised, they could lead to further share issuances before expiry.

If all remaining BCMAF options are exercised at $0.011 each, the company could raise approximately $1.15 million in gross proceeds, with a corresponding increase in ordinary shares outstanding. Investors should be aware of this dilution potential, although the timing and likelihood of exercise depend on market conditions and BCM’s share price relative to the exercise price. No guidance on expected conversion timing was provided in this update.

Overview of Brazilian Critical Minerals’ Unquoted Securities Post-Conversion

The Appendix 2A filing also details the company’s unquoted securities as of this update. In addition to the 104,595,830 outstanding BCMAF options, Brazilian Critical Minerals holds several other unquoted securities: 89,225,000 BCMAD options expiring 23 December 2027 with a $0.0175 exercise price; 89,600,000 BCMAB performance rights; 3,000,000 BCMAA options expiring 20 December 2026 at $0.05; 50,000,000 BCMAG options expiring 1 October 2028 at $0.04; and 50,000,000 BCMAE options expiring 15 December 2028 at $0.0175.

Collectively, these unquoted securities represent significant potential future share issuances and, for options, future cash inflows if exercised. Performance rights convert to shares upon meeting performance conditions without cash payment; these conditions were not detailed in this update. Investors should consider this full suite of securities when evaluating BCM’s potential future share count.

Background on BCMAF Option Issuance and Structure

The BCMAF options, formally titled "OPTION EXPIRING 12-AUG-2027 EX $0.011," are among several option tranches issued by Brazilian Critical Minerals as part of its capital and incentive management strategy. The filing confirms these options were not issued under an employee incentive scheme, unlike the BCMAB performance rights which may have different vesting and conversion terms.

The low exercise price of $0.011 reflects market conditions at the time of issuance, consistent with the low single-cent trading prices typical for early-stage ASX mineral explorers. The commencement of option exercises suggests market conditions have made conversion economically viable for some holders. The company did not disclose the identities or nature of the exercising option holders.

Sector Context for BCM Investors in Critical Minerals

As its name suggests, Brazilian Critical Minerals focuses on critical minerals projects in Brazil. Critical minerals—key for batteries, defence, and clean energy supply chains—have attracted global investor and government interest recently. Both Australia and Brazil are recognized as important potential suppliers. BCM’s ASX listing places it within a sector experiencing significant capital flows and speculative interest, though outcomes vary widely based on project quality, management, and commodity price cycles.

While option exercises and resulting share issuances dilute shareholdings, these are standard corporate actions for companies at BCM’s development stage and do not, by themselves, indicate operational milestones. Investors seeking insight into exploration progress, resource estimates, or strategic direction should consult the company’s broader announcements and quarterly reports, which provide operational details beyond routine securities filings.

New Shares Hold Equal Rights With Existing BCM Ordinary Shares

The Appendix 2A filing confirms that the 8,395,832 newly issued shares rank equally with all existing BCM ordinary shares from their issue date of 1 July 2026. This means new shareholders—those who exercised BCMAF options—have the same economic and voting rights as existing holders, including entitlement to dividends, capital returns, and corporate actions.

Equal ranking of newly issued shares complies with ASX listing rules and assures both new and current shareholders that no preferential treatment exists. Given the relatively small size of this tranche compared to nearly 1.97 billion total shares, the immediate impact on existing shareholders’ proportional holdings is minimal, although cumulative conversions over time may have a more significant effect.

Upcoming BCMAA Option Expiry in December 2026 Marks Next Capital Structure Event

Following the BCMAF conversion, the next notable date is the expiry of 3,000,000 BCMAA options on 20 December 2026, with an exercise price of $0.05—substantially higher than BCMAF options. Whether holders exercise these will depend heavily on BCM’s share price performance before expiry.

Beyond December 2026, multiple option tranches extend into 2027 and 2028, including 89,225,000 BCMAD options and 50,000,000 each of BCMAE and BCMAG options. These represent key milestones on BCM’s unquoted securities calendar over the coming two years. Investors and analysts should monitor whether operational progress supports share price levels sufficient to incentivize exercise of higher-priced options.

Share Price Impact and Investor Focus

The immediate share price impact of this update was not evident from public information. Routine option conversions and share quotation applications typically do not trigger significant price movements, as they are expected events under existing securities arrangements. Market reaction, if any, will depend on broader sentiment toward BCM and the critical minerals sector at the time.

Investors in Brazilian Critical Minerals are likely focused on substantive operational developments such as exploration results, resource updates, or partnership and funding announcements related to the company’s Brazilian critical minerals projects, which more directly influence share price. The next key capital structure event is the BCMAA option expiry in December 2026, while operational updates are expected in forthcoming quarterly activity reports.